FDA Drug Application (022396) for DYLOJECT by JAVELIN PHARMS INC

Back to FDA Applications sponsored by JAVELIN PHARMS INC

Application Number022396
Product Number001
FormSOLUTION;INTRAVENOUS
Dosage37.5MG/ML (37.5MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDYLOJECT
Active IngredientDICLOFENAC SODIUM

Active IngredientCount
List of drugs with Active Ingredient DICLOFENAC SODIUM8


Back to FDA Applications sponsored by JAVELIN PHARMS INC